+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure



Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure



Sleep Medicine 27-28: 45-48



We aimed to examine the relationship between subjective and objective sleepiness in obstructive sleep apnea syndrome (OSAS) patients with residual sleepiness, and to determine whether baseline objective sleepiness severity predicts the response to modafinil therapy. Data were obtained from a randomized, placebo-controlled modafinil (200 mg/day) study in Japanese OSAS patients with residual sleepiness receiving nasal continuous positive pressure (n-CPAP) treatment. We analyzed 50 participants whose subjective (Epworth Sleepiness Scale [ESS] total score) and objective (Maintenance of Wakefulness Test [MWT] sleep latency) sleepiness were evaluated before and after treatment. Subjects were dichotomized into two subgroups according to the mean baseline MWT sleep latency. ESS total score and MWT sleep latency changes after treatment were compared between the placebo and modafinil groups in both subgroups. The mean baseline ESS total score and MWT sleep latency were 14.1 ± 2.8 and 14.2 ± 4.9 min, respectively; there was no significant correlation between these two variables. Patient characteristics were similar between the two subgroups (MWT sleep latency: <14 min, n = 23; ≥14 min, n = 27). In the <14-min subgroup, changes in ESS total score and MWT sleep latency after treatment were significantly greater in the modafinil group than in the placebo group (p = 0.005). In the ≥14-min subgroup, changes in these parameters did not differ between the treatment groups. In OSAS patients with residual sleepiness, the objective sleepiness level was not as high as expected, despite increased subjective sleepiness. Improvements in subjective and objective sleepiness seemed difficult to achieve with modafinil treatment among subjects with less objective sleepiness.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057878268

Download citation: RISBibTeXText

PMID: 27938918

DOI: 10.1016/j.sleep.2016.06.035


Related references

Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. Journal of Clinical Sleep Medicine 9(8): 751-757, 2013

Modafinil improves behavioral alertness in patients with Obstructive Sleep Apnea (OSA) treated with Nasal Continuous Positive Airway Pressure (nCPAP) with Residual Excessive Sleepiness (ES). 2007

Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 28(4): 464-471, 2005

Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy. Sleep and Breathing 2019:, 2019

Positron emission tomography findings in obstructive sleep apnea patients with residual sleepiness treated with continuous positive airway pressure. Journal of Physiology and Pharmacology 58 Suppl 5(Pt 1): 25-35, 2007

Positron emission tomography findings in obstructive sleep APNEA patients with residual sleepiness treated with continuous positive airway pressure. Journal of Physiology and Pharmacology 58(Suppl. 5, Part 1): 25-35, 2007

Effect of adherence on daytime sleepiness, fatigue, depression and sleep quality in the obstructive sleep apnea/hypopnea syndrome patients undertaking nasal continuous positive airway pressure therapy. Patient Preference and Adherence 11: 769-779, 2017

Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: Effects of chronic treatment and 1-night therapy withdrawal. Sleep 18(3): 195-201, 1995

Residual excessive sleepiness in patients with obstructive sleep apnea on treatment with continuous positive airway pressure. Current Opinion in Pulmonary Medicine 22(6): 589-594, 2016

Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Sleep Medicine 14(10): 955-963, 2013

Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management. Sleep Medicine Clinics 11(3): 353-363, 2016

Nursing Interventions Improve Continuous Positive Airway Pressure Adherence in Obstructive Sleep Apnea With Excessive Daytime Sleepiness: A Systematic Review. Rehabilitation Nursing 2018:, 2018

Residual Sleepiness On Continuous Positive Airway Pressure (Cpap) Therapy In Patients With Obstructive Sleep Apnea (Osa). Sleep 40(Suppl_1): A190-A191, 2017

Effects of continuous positive airway pressure on daytime sleepiness in patients with severe obstructive sleep apnea syndrome. Zhonghua Yi Xue Za Zhi 94(6): 412-415, 2014

Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 127(3): 710-715, 2005